A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine

Gregers Jungersen; Aneesh Thakur; Claus Aagaard; Peter Andersen; Heidi Mikkelsen Melvang

A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine

Gregers Jungersen (Inventor), Aneesh Thakur (Inventor), Claus Aagaard (Inventor), Peter Andersen (Inventor), Heidi Mikkelsen Melvang (Inventor)

Research output: Patent

Abstract

The present invention provides one or more immunogenic polypeptides for use in a preventive or therapeutic vaccine against latent or active infection in a human or animal caused by a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Furthermore a single or multi-phase vaccine comprising the one or more immunogenic polypeptides is provided for administration for the prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Additionally, nucleic acid vaccines, capable of in vivo expression of the multi-phase vaccine comprising the one or more immunogenic polypeptides, is provided for prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis.

Original language	English
IPC	A61K39/04
Patent number	WO2014114812
Filing date	31/07/2014
Country/Territory	International Bureau of the World Intellectual Property Organization (WIPO)
Priority date	28/01/2013
Priority number	EP20130152908
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SFX availability

Full text

Cite this

@misc{138f48c6b93c4577b54b6aa69e6e5b0d,

title = "A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine",

abstract = "The present invention provides one or more immunogenic polypeptides for use in a preventive or therapeutic vaccine against latent or active infection in a human or animal caused by a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Furthermore a single or multi-phase vaccine comprising the one or more immunogenic polypeptides is provided for administration for the prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Additionally, nucleic acid vaccines, capable of in vivo expression of the multi-phase vaccine comprising the one or more immunogenic polypeptides, is provided for prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis.",

author = "Gregers Jungersen and Aneesh Thakur and Claus Aagaard and Peter Andersen and Melvang, {Heidi Mikkelsen}",

year = "2014",

language = "English",

type = "Patent",

note = "WO2014114812; A61K39/04",

}

TY - PAT

T1 - A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine

AU - Jungersen, Gregers

AU - Thakur, Aneesh

AU - Aagaard, Claus

AU - Andersen, Peter

AU - Melvang, Heidi Mikkelsen

PY - 2014

Y1 - 2014

N2 - The present invention provides one or more immunogenic polypeptides for use in a preventive or therapeutic vaccine against latent or active infection in a human or animal caused by a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Furthermore a single or multi-phase vaccine comprising the one or more immunogenic polypeptides is provided for administration for the prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Additionally, nucleic acid vaccines, capable of in vivo expression of the multi-phase vaccine comprising the one or more immunogenic polypeptides, is provided for prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis.

AB - The present invention provides one or more immunogenic polypeptides for use in a preventive or therapeutic vaccine against latent or active infection in a human or animal caused by a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Furthermore a single or multi-phase vaccine comprising the one or more immunogenic polypeptides is provided for administration for the prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Additionally, nucleic acid vaccines, capable of in vivo expression of the multi-phase vaccine comprising the one or more immunogenic polypeptides, is provided for prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis.

M3 - Patent

M1 - WO2014114812

Y2 - 2014/07/31

ER -

A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine

Abstract

UN SDGs

SFX availability

Fingerprint

Cite this